Policy | August 13, 2022
MoU signed between Ministry of Ayush and MeitY
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
MeitY will provide technical support for digitalisation of the Ayush Sector under the Ayush Grid project for a period of three years
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
EBITDA stood at Rs. 39.9 crore and EBITDA margin for the quarter was 38.2% whereas Profit After Tax (PAT) stood at Rs. 17.5 crore translating into a PAT margin of 16.7%
Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reduced risk of disease progression or death by 50% and increased overall survival by more than six months versus chemotherapy
The 562,000 square feet facility has been recognized as the first and largest integrated insulin manufacturer in Malaysia by MBR
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
Lupin is the 6th largest company in the Indian Pharmaceutical Market
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Subscribe To Our Newsletter & Stay Updated
